Kim Ji Won Challenges Japan's Medical Drama Legacy

The surgical doors swing open, revealing Kim Ji Won in her first still from the upcoming drama. Dressed in pristine white scrubs, her expression is cold, her gaze defiant. This isn't the warm, empathetic actress audiences know—this is a surgeon ready for war.

SBS dropped this image as part of their 2026 drama lineup announcement on February 10, showcasing "Doctor X: Age of the White Mafia." The Korean adaptation of Japan's beloved medical series promises to thrust Kim Ji Won into uncharted territory as a lone medical antihero battling corruption in a hospital system riddled with power plays and greed.

The Weight of a 20% Rating Legacy

The original "Doctor X" isn't just any medical drama—it's a cultural phenomenon that dominated Japanese television for 11 years. The series, centered on freelance surgeon Michiko Daimon and her iconic catchphrase "I never fail," consistently pulled in ratings above 20%, making it appointment television for millions.

The Korean version faces the formidable task of translating this success across cultural boundaries. Kim Ji Won's character will navigate the treacherous politics of university hospitals, where medical decisions often bow to financial interests and institutional hierarchies. But this isn't a simple remake—the adaptation promises to reflect the unique realities of Korea's medical landscape.

For Kim Ji Won, this represents a dramatic departure from her previous roles. Known for her heartwarming performances in "Descendants of the Sun" and "Fight for My Way," she's now stepping into the shoes of a character defined by surgical precision and emotional distance. The transformation could either cement her versatility or expose the limitations of typecasting.

The Global Stakes of K-Drama Adaptation

This isn't just another drama launch—it's a litmus test for K-drama's evolving global influence. With Korean content dominating Netflix charts worldwide, the success of a Japanese-to-Korean adaptation carries implications far beyond domestic ratings.

Korea has already proven its medical drama credentials with hits like "Good Doctor" and "Dr. Romantic." Adding Japan's proven storytelling framework could create a powerful hybrid that appeals to both regional and international audiences. The question is whether global viewers will embrace a Korean take on a distinctly Japanese narrative.

Yet skeptics wonder if the cultural translation will resonate. Japanese workplace hierarchies and medical ethics differ significantly from Korean contexts. The challenge lies in maintaining the original's sharp critique of institutional corruption while making it authentically Korean.

SBS has scheduled the series for its premium Friday-Saturday slot, signaling confidence in its prime-time appeal. The network promises to preserve the original's edge while infusing distinctly Korean sensibilities.

The Antihero's Gamble

Perhaps the most intriguing aspect is Kim Ji Won's casting against type. The actress built her reputation on relatability and warmth—qualities that seem antithetical to the cold, calculating surgeon she's now portraying. This casting choice reflects a broader trend in K-drama: established stars taking creative risks to expand their range.

The medical drama genre itself is experiencing a renaissance, with audiences craving more complex, morally ambiguous protagonists. Kim Ji Won's surgeon represents this shift—a character who saves lives while dismantling systems, who heals while harboring emotional wounds.